Skip to content

Aura Biosciences, Inc. AURA Net Investment in Lease

Net Investment in Lease at other companies

ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
CG Oncology logo
CG OncologyCGON
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
Nuvation Bio logo
Nuvation BioNUVB
Immunome logo
ImmunomeIMNM

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$709.23M+89.4%
Enterprise value$641.43M+80.8%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aura Biosciences, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aura Biosciences, Inc.'s net investment in lease?
Aura Biosciences, Inc. (AURA) reported net investment in lease of $15.42M in Q1 2026.
How has Aura Biosciences, Inc.'s net investment in lease changed year-over-year?
Aura Biosciences, Inc.'s net investment in lease decreased by 9.3% year-over-year, from $17.01M to $15.42M.
What is the long-term trend for Aura Biosciences, Inc.'s net investment in lease?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s net investment in lease has grown at a 102.0% compound annual growth rate (CAGR), from $950K to $15.83M.